Recent Advances in Indocyanine Green-Based Probes for NIR-II Fluorescence Imaging and Therapy
Dehong Hu,
No information about this author
Menglei Zha,
No information about this author
Hairong Zheng
No information about this author
et al.
Research,
Journal Year:
2024,
Volume and Issue:
8
Published: Dec. 27, 2024
Fluorescence
imaging,
a
highly
sensitive
molecular
imaging
modality,
is
being
increasingly
integrated
into
clinical
practice.
Imaging
within
the
second
near-infrared
biological
window
(NIR-II;
1,000
to
1,700
nm),
also
referred
as
shortwave
infrared,
has
received
substantial
attention
because
of
its
markedly
reduced
autofluorescence,
deeper
tissue
penetration,
and
enhanced
spatiotemporal
resolution
compared
traditional
(NIR)
imaging.
Indocyanine
green
(ICG),
US
Food
Drug
Administration-approved
NIR
fluorophore,
long
been
used
in
applications,
including
blood
vessel
angiography,
vascular
perfusion
monitoring,
tumor
detection.
Recent
advancements
NIR-II
technology
have
revitalized
interest
ICG,
revealing
extended
tail
fluorescence
beyond
nm
reaffirming
potential
clinically
translatable
fluorophore
for
vivo
theranostic
applications
diagnosing
various
diseases.
This
review
emphasizes
notable
advances
use
ICG
derivatives
image-guided
therapy
from
both
fundamental
perspectives.
We
provide
concise
conclusion
discuss
challenges
future
opportunities
with
using
approved
fluorophores.
Language: Английский
Ultrafine Fiber-Mediated Transvascular Interventional Photothermal Therapy Using Indocyanine Green for Precision Embolization Treatment
Yingao Ma,
No information about this author
Jingyu Xiao,
No information about this author
Jinna Chen
No information about this author
et al.
Biomaterials Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
A
transvascular
interventional
photothermal
therapy
was
developed
to
simultaneously
deliver
agents
while
performing
laser
irradiation
via
an
endovascular
route
for
precision
embolization
treatment.
Language: Английский
Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based breast cancer therapies
Javad Mohammadi,
No information about this author
Sina Ebrahimi,
No information about this author
Maryam Ghodousi
No information about this author
et al.
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 106249 - 106249
Published: Oct. 1, 2024
Language: Английский